Anesthesia and Respiratory Devices Market
Anesthesia circuits are utilized for a variety of diagnostic and therapeutic surgical procedures ... Read More
SGLT2 is a member of the sodium-glucose cotransporter family which are sodium-dependent glucose transport proteins. SGLT2 is the major cotransporter involved in glucose reabsorption in the kidney.The growing global type-2 diabetes population promotes the growth of SGLT2 drugs.
This report contains market size and forecasts of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors in global, including the following market information:
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors companies in 2021 (%)
The global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Invokana (Canagliflozin) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors include Eli Lilly, Janssen Pharmaceuticals, Astellas, Boehringer Ingelheim, AstraZeneca, Bristol Myers Squibb and Kotobuki Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segment Percentages, by Type, 2021 (%)
Invokana (Canagliflozin)
Jardiance (Empagliflozin)
Farxiga/Forxiga (Dapagliflozin)
Suglat (Ipragliflozin)
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segment Percentages, by Application, 2021 (%)
Hospital
Medical Research Institute
Other
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors revenues share in global market, 2021 (%)
Key companies Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Sodium/Glucose Cotransporter 2 (SGLT 2) Inhibitors sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Janssen Pharmaceuticals
Astellas
Boehringer Ingelheim
AstraZeneca
Bristol Myers Squibb
Kotobuki Pharmaceutical
Anesthesia circuits are utilized for a variety of diagnostic and therapeutic surgical procedures ... Read More
Antifungal drugs are used to treat fungal infections, which most commonly affect your skin, hair ... Read More
Tuberculosis (TB) is a disease affecting the population across the world. Although tuberculosis i ... Read More
Asthma is refered to a chronic respiratory disease which blocks the airways of lung because of mu ... Read More